South Korea, China lead degrader-antibody conjugate growth: record
Pictures from Envato Business from these nations have 19 of the 28 properties worldwide. South Korea and China are creating deliquent antibody conjugates (DACS), an arising accuracy medication targeted treatment, GlobalData stated.